White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Generic Market Review 2023 29 June 2023 The Generic Medicines Group Market Access Committee is pleased to…
Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
Market Review – European Generic Medicine Markets 2020 1 March 2021 Open
Market review Generic medicines policy 2023 - Policy… 29 June 2023 The Generic Market Access Committee (Generic medicines Group, a Medicines…